Laszlo Joseph Szarka, 89600 4Th St SW APT 504, Rochester, MN 55902

6468781, Oct 22, 2002

Feb 22, 2000

09/510925

Ronald Hanson - Morris Plains NJ
Mary Jo Donovan - North Brunswick NJ
Steven Goldberg - Gillette NJ
Paul A. Jass - Charles City IA
Wen-Sen Li - Holmdel NJ
Ramesh Patel - Bridgewater NJ
Keith Ramig - Orange NJ
Laszlo J. Szarka - East Brunswick NJ
John J. Venit - North Brunswick NJ

Bristol-Myers Squibb Company - Princeton NJ

C12P 2106

4352551, 435 692, 435183, 435189, 4352521

Processes for stereoselective enzymatic conversion of certain keto carboxylic acid derivatives to form the corresponding alkylamino acid compounds are described. The invention also concerns an engineered yeast host cell containing recombinant nucleic acid capable of expressing a phenylalanine dehydrogenase, as well as an engineered host cell containing recombinant nucleic acid capable of expressing a phenylalanine dehydrogenase enzyme and nucleic acid capable of expressing a formate dehydrogenase enzyme.

6515170, Feb 4, 2003

Apr 26, 2001

09/843226

Ramesh N. Patel - Bridgewater NJ
Amit Banerjee - St. Louis MO
Venkata B. Nanduri - East Brunswick NJ
Steven L. Goldberg - Basking Ridge NJ
Robert M. Johnston - Whitehouse Station NJ
Thomas P. Tully - Middlesex NJ
Laszlo J. Szarka - East Brunswick NJ
Shankar Swaminathan - North Brunswick NJ
John J. Venit - North Brunswick NJ
Jerome L. Moniot - Chester NJ
William J. Winter - New Brunswick NJ
Neal G. Anderson - Stockton NJ
David A. Lust - Roosevelt NJ
Gerard Crispino - Princeton NJ
Sushil K. Srivastava - Dayton NJ

Bristol-Myers Squibb Co. - Princeton NJ

C07C 3200

562432, 562433, 562426, 562485, 562400

The present invention concerns an enzymatic oxidative deamination process of a dipeptide monomer to prepare an intermediate useful to prepare compounds having endopeptidase and angiotensin converting enzyme inhibition activity.

5413935, May 9, 1995

Mar 24, 1993

8/106182

Ramesh N. Patel - Bridgewater NJ
Clyde G. McNamee - Lawrenceville NJ
Laszlo J. Szarka - East Brunswick NJ

E. R. Squibb & Sons, Inc. - Princeton NJ

C12P 4100

435280

An enantiomerically pure compound of the formula ##STR1## is prepared when the associated racemic mixture is reacted with an acrylating agent R. sup. 3 --C(O)--O--R in the presence of a microorganism or enzyme derived therefrom capable of catalyzing transesterification of an alcohol. X. sup. 1 and X. sup. 2 are each independently halogen, R is alkyl, R. sup. 1 and R. sup. 2 are each independently alkyl, cycloalkyl, aralkyl or aryl and R. sup. 3 is alkyl, cycloalkyl, aryl or aralkyl.

5986095, Nov 16, 1999

Jan 6, 1992

7/817232

Ronald L. Hanson - Morris Plains NJ
Ramesh N. Patel - Bridgewater NJ
Laszlo J. Szarka - East Brunswick NJ

E.R. Squibb & Sons, Inc. - Princeton NJ

C07D40304

544295

A process is described for preparing a compound of the formula or the S-enantiomer thereof, wherein: R is alkyl, aryl, cycloalkyl, aralkyl, or cycloalkylalkyl, R. sup. 1 is halogen; R. sup. 2 is halogen, alkyl, cycloalkyl, aryl or ##STR1## wherein the process comprises treating the associated racemic alcohol with an acylating agent ##STR2## (wherein L is a leaving group) and an enzyme or microorganism capable of enantioselective acylation. This process may also be used to isolate the unreacted R- or S-alcohol. The acylated product may be enantioselectively hydrolyzed with a lipase or lipase-supplying microorganism to the S- or R-alcohol. Compounds prepared by this invention are useful antipsychotic agents or useful intermediates therefor.

4208481, Jun 17, 1980

Nov 16, 1978

5/961306

Laszlo J. Szarka - East Brunswick NJ
Robert W. Eltz - Princeton NJ

E. R. Squibb & Sons, Inc. - Princeton NJ

C12P 3700

435 43

Benzylpenicillin is prepared by culturing a penicillin-producing microorganism in a medium containing suitable sources of nitrogen, carbon and energy, and inorganic salts. One or more phenylalkanes of the formula ##STR1## wherein n is an integer from 6 to 13 are included within the medium as the sidechain precursor.

5739016, Apr 14, 1998

May 19, 1995

8/445120

Ronald L. Hanson - Morris Plains NJ
Ramesh N. Patel - Bridgewater NJ
Laszlo J. Szarka - East Brunswick NJ

Bristol-Myers Squibb Company - Princeton NJ

C12P 1702
C12N 914

435117

An enzymatic hydrolysis method for the preparation of compounds useful as intermediates in the preparation of taxanes such as taxol, wherein one or more C-13 acyloxy-bearing taxanes are contacted with an enzyme or microorganism capable of hydrolyzing said acyloxy groups to hydroxyl groups.

5516676, May 14, 1996

Jun 15, 1993

8/077979

Ronald L. Hanson - Morris Plains NJ
Ramesh N. Patel - Bridgewater NJ
Laszlo J. Szarka - East Brunswick NJ

Bristol-Myers Squibb Company - Princeton NJ

C12P 1702
C12N 914
C07D30514

435195

Compounds useful as intermediates in the preparation of taxanes such as taxol are prepared by contacting one or more C-13 acyloxy-bearing taxanes with an enzyme or microorganism capable of hydrolyzing said acyloxy groups to hydroxyl groups. In a preferred embodiment the microorganism is Nocardioides albus ATCC55424, Nocardioides albus ATCC55425 or Nocardioides luteus ATCC55426 or the hydrolase enzyme is isolated from the microorganisms.

5620876, Apr 15, 1997

Apr 29, 1992

7/875859

Brian L. Davis - Dayton NJ
Paul M. Cino - Bound Brook NJ
Laszlo J. Szarka - East Brunswick NJ

E. R. Squibb & Sons, Inc. - Princeton NJ

C12P 740
A61K 31425

435136

Enzymatic hydrolysis and esterification processes for the preparation of compounds useful as HMG-CoA reductase inhibitors and/or as intermediates in the preparation of HMG-CoA reductase inhibitors.